Kadomatsu K - Search Results

1

Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.

Murakami-Tonami Y, Kishida S, Takeuchi I, Katou Y, Maris JM, Ichikawa H, Kondo Y, Sekido Y, Shirahige K, Murakami H, Kadomatsu K. Murakami-Tonami Y, et al. Among authors: kadomatsu k. Cell Cycle. 2014;13(7):1115-31. doi: 10.4161/cc.27983. Epub 2014 Feb 7. Cell Cycle. 2014. PMID: 24553121 Free PMC article.

2

Plasma midkine level is a prognostic factor for human neuroblastoma.

Ikematsu S, Nakagawara A, Nakamura Y, Ohira M, Shinjo M, Kishida S, Kadomatsu K. Ikematsu S, et al. Among authors: kadomatsu k. Cancer Sci. 2008 Oct;99(10):2070-4. doi: 10.1111/j.1349-7006.2008.00957.x. Cancer Sci. 2008. PMID: 19016768 Free PMC article.

3

Transforming growth factor-beta1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury.

Yin J, Sakamoto K, Zhang H, Ito Z, Imagama S, Kishida S, Natori T, Sawada M, Matsuyama Y, Kadomatsu K. Yin J, et al. Among authors: kadomatsu k. Brain Res. 2009 Mar 31;1263:10-22. doi: 10.1016/j.brainres.2009.01.042. Epub 2009 Feb 3. Brain Res. 2009. PMID: 19368826

4

DRR1 is expressed in the developing nervous system and downregulated during neuroblastoma carcinogenesis.

Asano Y, Kishida S, Mu P, Sakamoto K, Murohara T, Kadomatsu K. Asano Y, et al. Among authors: kadomatsu k. Biochem Biophys Res Commun. 2010 Apr 9;394(3):829-35. doi: 10.1016/j.bbrc.2010.03.085. Epub 2010 Mar 16. Biochem Biophys Res Commun. 2010. PMID: 20298674

5

The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma.

Huang P, Kishida S, Cao D, Murakami-Tonami Y, Mu P, Nakaguro M, Koide N, Takeuchi I, Onishi A, Kadomatsu K. Huang P, et al. Among authors: kadomatsu k. Cancer Res. 2011 Apr 15;71(8):2938-48. doi: 10.1158/0008-5472.CAN-10-3524. Epub 2011 Feb 24. Cancer Res. 2011. PMID: 21349947

6

Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.

Sonobe Y, Li H, Jin S, Kishida S, Kadomatsu K, Takeuchi H, Mizuno T, Suzumura A. Sonobe Y, et al. Among authors: kadomatsu k. J Immunol. 2012 Mar 15;188(6):2602-11. doi: 10.4049/jimmunol.1102346. Epub 2012 Feb 8. J Immunol. 2012. PMID: 22323540

7

Midkine promotes neuroblastoma through Notch2 signaling.

Kishida S, Mu P, Miyakawa S, Fujiwara M, Abe T, Sakamoto K, Onishi A, Nakamura Y, Kadomatsu K. Kishida S, et al. Among authors: kadomatsu k. Cancer Res. 2013 Feb 15;73(4):1318-27. doi: 10.1158/0008-5472.CAN-12-3070. Epub 2012 Dec 14. Cancer Res. 2013. PMID: 23243020

8

The heparin-binding growth factor midkine: the biological activities and candidate receptors.

Kadomatsu K, Kishida S, Tsubota S. Kadomatsu K, et al. J Biochem. 2013 Jun;153(6):511-21. doi: 10.1093/jb/mvt035. Epub 2013 Apr 26. J Biochem. 2013. PMID: 23625998 Review.

9

Discovering combinatorial interactions in survival data.

Duverle DA, Takeuchi I, Murakami-Tonami Y, Kadomatsu K, Tsuda K. Duverle DA, et al. Among authors: kadomatsu k. Bioinformatics. 2013 Dec 1;29(23):3053-9. doi: 10.1093/bioinformatics/btt532. Epub 2013 Sep 13. Bioinformatics. 2013. PMID: 24037215 Free PMC article.

10

Involvement of midkine in neuroblastoma tumourigenesis.

Kishida S, Kadomatsu K. Kishida S, et al. Among authors: kadomatsu k. Br J Pharmacol. 2014 Feb;171(4):896-904. doi: 10.1111/bph.12442. Br J Pharmacol. 2014. PMID: 24116381 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters